Clinical Roundup Study finds expanded predictive value of Breast Cancer Index for ovarian function suppression in SOFT trial December 09, 2022Vol.48 No.44
Clinical Roundup Estrogen-blocking drugs could offer mortality benefit for women with elevated breast cancer risk December 02, 2022Vol.48 No.43
Clinical Roundup Multicenter study reveals worse outcomes in understudied breast cancer December 02, 2022Vol.48 No.43
Clinical Roundup Drug shows promise in overcoming endocrine therapy resistance in breast cancer November 18, 2022Vol.48 No.42
Cancer History ProjectConversation with The Cancer LetterFree Craig Jordan on discovering tamoxifen’s role in breast cancer—and a lifetime of innovation November 11, 2022Vol.48 No.41By Alexandria Carolan
In Brief Jeannie Shen named medical director of the Breast Program and the International Health Program at the Cedars-Sinai affiliate November 04, 2022Vol.48 No.40
In Brief Max Foundation, ABC Global Alliance, American Society of Clinical Pathology, Cepheid, Novartis AG collaborate to improve advanced breast cancer outcomes in low-resource countries October 28, 2022Vol.48 No.39
Clinical Roundup In phase II study, Talzenna shrank tumors in breast cancer patients with PALB2 mutations October 28, 2022Vol.48 No.39
Clinical Roundup VCU Massey scientists pinpoint druggable target in TNBC October 28, 2022Vol.48 No.39
